Oil Prices Tumble Over 5 on Hopes of Iran Nuclear Deal Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report How Dropboxs RemoteFirst Model Drives Recruitment and Retention Amid ReturntoOffice Trends Italian Top Court Ruling on Tap Water May Shape Hospitality Policies in Tourist Regions Teo Siong Seng Shipping Tycoon Facing Antitrust Allegations Over Container Pricing US Productivity Growth Moderates in Q4 as Labor Costs Rise What It Means for Inflation and Earnings Viking Holdings VIK Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market BLCO Q1 2026 Earnings EPS Surpasses Estimates by 365 Despite Slight Stock Decline CONMED Corporation CNMD Q1 2026 Earnings EPS Beat Amid Margin Improvement IHG Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Market Conditions IHG Q4 2025 Earnings EPS Misses Estimates but Stock Rises Modestly RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed Forafric Global PLC Warrants AFRIW Holds Steady at 075 Amid Tight Trading Range Ciena Corporation CIEN Edges Lower Amid Mixed Market Sentiment Key Levels in Focus Eaton Corporation ETN Dips 113 as Support Levels Come into View Nauticus Robotics Warrants KITTW Stalled at 002 Little Movement Low Visibility Genuine Parts Company GPC Edges Lower as It Tests Key Support Zone SP 500 Edges Higher as Technology and Healthcare Lead Defensive Sectors Lag Under Armour Q1 2026 Earnings A Mixed Quarter with EPS Miss but Stock Gains Fiserv Inc FISV Holds Steady Near Support as Market Awaits Catalyst Provident Financial Services PFS Holds Steady Near Support Amid Quiet Trading Floor Decor FND Holds Steady Near Support as Modest Gains Signal Cautious Market Stance TrioTech International TRT Slips 456 Key Support Test in Play After Sharp Pullback Nuveen Municipal Value Fund NUV Holds Steady A Modest Uptick Amidst RangeBound Trading Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone ADTRAN Holdings ADTN Surges 523 as Stock Approaches Key Resistance Level Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces